利拉鲁肽对新诊断2型糖尿病合并肥胖/超重男性病人的血睾酮水平的影响

赵琳; 刘洋; 申晶

doi:10.13898/j.cnki.issn.1000-2200.2018.04.022

留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

利拉鲁肽对新诊断2型糖尿病合并肥胖/超重男性病人的血睾酮水平的影响

赵琳 , 刘洋 , 申晶

文章导航 > 蚌埠医学院学报 > 2018, 43 > 4: (501-502,506)

引用本文:

Citation:

利拉鲁肽对新诊断2型糖尿病合并肥胖/超重男性病人的血睾酮水平的影响

解放军第309医院内分泌科, 北京 100091

作者简介: 赵琳(1979-),女,博士,主治医师.

通讯作者: 申晶, 副主任医师.shenjingshenhua@126.com

中图分类号: R587.1

Effect of liraglutide on the plasma testosterone level in T2DM male patiens complicated with obesity/overweight

Department of Endocrinololy, The 309 th PLA Hospital, Beijing 100091, China

Corresponding author: SHEN Jing, 副主任医师.shenjingshenhua@126.com

CLC number: R587.1

摘要: 目的：探讨皮下注射利拉鲁肽注射液治疗新诊断2型糖尿病（T2DM）合并肥胖/超重男性病人对血浆睾酮水平的影响。方法：入组新诊断肥胖/超重T2DM男性病人40例，随机分为在原治疗方案的基础上加用利拉鲁肽20例（观察组）和不加用利拉鲁肽20例（对照组），治疗6个月，观察利拉鲁肽注射液的临床疗效和对血浆睾酮的水平变化的影响。结果：治疗前2组空腹血糖（FPG）、糖化血红蛋白（HbA1c）、胰岛素抵抗指数（HOMA-IR）、胰岛β细胞功能指数（HOMA-β）差异均无统计学意义（P>0.05）。治疗后，对照组FPG和HbA1c较治疗前明显改善（P<0.01），观察组各项指标均较治疗前明显改善（P<0.01）；且与对照组比较，观察组FPG和HbA1c均降低（P<0.05和P<0.01），HOMA-β明显升高（P<0.01）。治疗后观察组睾酮水平明显高于治疗前（P<0.01），而对照组治疗前后睾酮水平差异无统计学意义（P>0.05）；治疗前后，2组睾丸酮水平间差异均无统计学意义（P>0.05）。结论：利拉鲁肽能有效降低新诊断T2DM合并肥胖/超重病人血糖，改善胰岛β细胞功能，可提高血浆睾酮水平。
- 2型糖尿病 /
- 利拉鲁肽 /
- 睾酮 /
- 肥胖 /
- 超重
Abstract: Objective:To investigate the effects of liraglutide on the plasma testosterone level in type 2 diabetes mellitus(T2DM) male patients complicated with obesity/overweight.Methods:A total of 40 obese or overweight T2DM patients were randomly divided into the control group and observation group(20 cases each group).The control group and observation group were treated with routine method and liraglutide combined with routine method,respectively.After 6 months of treatment,the clinical effiency of liraglutide,and effect of liraglutide on the plasma testosterone level were observed.Results:Before treatment,the differences of the levels of FPG,HbA1c,HOMA-IR and HOMA-β between two groups were not statistically significant(P>0.05).After treatment,the levels of FPG and HbA1c in control group,and all indexes in observation group were significantly improved compared with before treatment(P<0.01).Compared with the control group,the levels of FPG and HbA1c,and level of HOMA-β in observation group significantly decreased and increased after treatment,respectively(P<0.05 to P<0.01).The plasma level of testosterone in observation group after treatment was significantly higher than that before treatment(P<0.01),and the difference of which in control group between before and after treatment was not statistically significant(P>0.05).The differences of the plasma levels of testosterone between two groups were not statistically significant before and after treatment(P>0.05).Conclusions:Liraglutide can effectively reduce the blood glucose,improve the function of pancreas islet β-cells,and enhance the plasma level of testosterone in T2DM patients complicated with obesity or overweight.
- type 2 diabetes mellitus /
- liraglutide /
- testosterone /
- obesity /
- overweight

[1]	安雅莉,高研,朱倩,等.不同体重指数新诊断2型糖尿病病人胰岛素分泌和胰岛素抵抗状况调查[J].中华医学杂志,2009,89(16):1117.
[2]	中华医学会内分泌学分会.中国2型糖尿病合并肥胖综合管理专家共识[J].中华内分泌代谢杂志,2016,32(8):623.
[3]	姚亚妮,朱枣兰,王玉玲.利拉鲁肽联合盐酸二甲双胍治疗维吾尔族与汉族肥胖2型糖尿病的临床疗效[J].新疆医科大学学报,2015,36(12):1527.
[4]	SALEHI M,AULINGER BA,D'ALESSIO DA.Targeting β-cell mass in type 2 diabetes promise and limimtions of new drugs based on incretins[J].Endocr Rev,2008,29(3):367.
[5]	TENOVER JS,MATSUMOTO AM,PLYMATE SR,et al.The effects of aging in normal men on bioavailable testosterone and luteinizing hormone secretion:reponse to clomiphernecitrate[J].J Clin Endocrinol Metab,1987,65(6):1118.
[6]	杜益君,潘天荣,钟兴,等.利拉鲁肽治疗不同2型糖尿病病程肥胖/超重病人的临床疗效及安全性观察[J].中国糖尿病杂志,2015,12(25):1066.
[7]	GARBER A,MATTHEWS D,ZINMAN B,et al.The effect of disease stage,indicated by number of previous oral antidiabetic[J].Diabetes,2011,60(suppl 1):967.
[8]	RAZ I,ELDOR R,CERMEA S.Diabetes:insulin resistance and derangements in lipid metabolism:Cure through intervention in fat transport and storage[J].Diabetes Metab Res Rev,2005,21(1):3.

[1]	王晶 , 刘哲 . 利拉鲁肽对肥胖及正常体质量2型糖尿病患者的降糖效果比较. 蚌埠医学院学报, 2016, 41(11): 1460-1461,1464. doi: 10.13898/j.cnki.issn.1000-2200.2016.11.017
[2]	章艳珍 , 方勤 , 李李 . 黄山地区居民地方特色食品摄入与超重/肥胖的相关性. 蚌埠医学院学报, 2017, 42(12): 1664-1667. doi: 10.13898/j.cnki.issn.1000-2200.2017.12.030
[3]	宋志毅 , 毕娅欣 . 蚌埠市汉族人群尾加压素Ⅱ基因S89N变异与2型糖尿病及肥胖的相关性. 蚌埠医学院学报, 2013, 37(6): 677-679,683.
[4]	席倩 . 肥胖对老年人2型糖尿病胰岛素及C肽应答的影响. 蚌埠医学院学报, 2004, 29(6): 501-503.
[5]	李娟 , 徐家新 , 王春 , 邵晨 , 周路路 . 利拉鲁肽通过AMPK/mTOR信号通路诱导自噬改善肝脂肪变性. 蚌埠医学院学报, 2022, 47(10): 1336-1341. doi: 10.13898/j.cnki.issn.1000-2200.2022.10.002
[6]	贾笑迪 , 裴晓艳 , 汪琼 , 于磊 , 庄兰艮 , 金国玺 . 2型糖尿病病人血清趋化素水平与腹型肥胖及大血管病变的关系. 蚌埠医学院学报, 2021, 46(5): 598-601. doi: 10.13898/j.cnki.issn.1000-2200.2021.05.010
[7]	伊桂叶 , 王家泰 , 董萍 , 周蒨 , 李晗 . 西格列汀治疗2型糖尿病肥胖患者40例疗效观察. 蚌埠医学院学报, 2013, 37(4): 434-436.
[8]	闫晓洁 , 王丽娜 , 温小明 . 肥胖型2型糖尿病二甲双胍单药治疗不理想者分别加用西格列汀与吡格列酮的疗效对比. 蚌埠医学院学报, 2018, 43(4): 503-506. doi: 10.13898/j.cnki.issn.1000-2200.2018.04.023
[9]	吴道爱 , 时照明 , 杨青青 , 吴晨辰 , 丁言稳 , 马博 . 双歧杆菌对2型糖尿病大鼠血浆酪酪肽和胰岛素抵抗的影响. 蚌埠医学院学报, 2019, 44(10): 1313-1315. doi: 10.13898/j.cnki.issn.1000-2200.2019.10.005
[10]	席倩 , 许华山 , 吴志昊 , 王佩 , 张翼 , 崔巍 . 儿童青少年超重、肥胖与代谢综合征的关系. 蚌埠医学院学报, 2011, 36(6): 602-605.
[11]	陆明 , 朱兰飞 , 李丹丹 , 纵亚丽 . 腹型肥胖与动脉粥样硬化及外周动脉疾病相关性研究. 蚌埠医学院学报, 2015, 40(2): 177-179,186. doi: 10.13898/j.cnki.issn.1000-2200.2015.02.012
[12]	范艳萍 , 石建华 , 项平 , 胡小磊 , 苗艳君 , 黄詠齐 . 糖皮质激素对肥胖大鼠和普通大鼠下丘脑神经肽Y mRNA的影响. 蚌埠医学院学报, 2009, 34(5): 369-371.
[13]	王晓琼 , 高华 . 阻塞性睡眠呼吸暂停低通气综合征病人的肥胖程度与血浆神经肽Y的相关性研究. 蚌埠医学院学报, 2017, 42(3): 320-322. doi: 10.13898/j.cnki.issn.1000-2200.2017.03.011
[14]	汪国胜 , 钟平 , 张雷 , 张蕾 , 马争飞 , 刘彬 . 高血压脑出血患者血清雌二醇、睾酮的变化及临床意义. 蚌埠医学院学报, 2014, 38(6): 745-748.
[15]	杨文选 , 余峰玲 , 周蕾 , 甘怀勇 , 刘从森 , 张涛 . 解脲脲原体感染对大鼠睾丸组织结构及睾酮水平的影响. 蚌埠医学院学报, 2015, 40(1): 1-4. doi: 10.13898/j.cnki.issn.1000-2200.2015.01.001
[16]	范静静 , 张晓梅 . 血浆内脂素、一氧化氮与2型糖尿病及糖尿病肾病的关系研究. 蚌埠医学院学报, 2012, 36(3): 267-270.
[17]	杜文华 , 石建华 , 项平 , 陈凤玲 . 营养性肥胖大鼠模型的建立与血糖、血脂变化. 蚌埠医学院学报, 2007, 32(4): 379-381.
[18]	徐浣白 , 石建华 , 张晓梅 , 陈凤玲 , 于磊 . 那格列奈治疗2型糖尿病的临床研究. 蚌埠医学院学报, 2005, 30(3): 237-239.
[19]	代雪飞 , 王建青 . 临床药师干预优化2型糖尿病病人胰岛素使用效果评价. 蚌埠医学院学报, 2021, 46(10): 1455-1458. doi: 10.13898/j.cnki.issn.1000-2200.2021.10.033
[20]	叶志恒 , 储小宏 , 贾丽 , 赵广碧 , 吴帮庆 . 绝经后糖耐量减低者性激素的变化. 蚌埠医学院学报, 2009, 34(1): 59-60.

点击查看大图

计量

文章访问数: 2501
HTML全文浏览量: 285
PDF下载量: 22
被引次数: 0

利拉鲁肽对新诊断2型糖尿病合并肥胖/超重男性病人的血睾酮水平的影响

通讯作者: 申晶, 副主任医师.shenjingshenhua@126.com

作者简介: 赵琳(1979-),女,博士,主治医师.

解放军第309医院内分泌科, 北京 100091

收稿日期: 2017-06-30
录用日期: 2018-01-13

关键词:

摘要: 目的：探讨皮下注射利拉鲁肽注射液治疗新诊断2型糖尿病（T2DM）合并肥胖/超重男性病人对血浆睾酮水平的影响。方法：入组新诊断肥胖/超重T2DM男性病人40例，随机分为在原治疗方案的基础上加用利拉鲁肽20例（观察组）和不加用利拉鲁肽20例（对照组），治疗6个月，观察利拉鲁肽注射液的临床疗效和对血浆睾酮的水平变化的影响。结果：治疗前2组空腹血糖（FPG）、糖化血红蛋白（HbA1c）、胰岛素抵抗指数（HOMA-IR）、胰岛β细胞功能指数（HOMA-β）差异均无统计学意义（P>0.05）。治疗后，对照组FPG和HbA1c较治疗前明显改善（P<0.01），观察组各项指标均较治疗前明显改善（P<0.01）；且与对照组比较，观察组FPG和HbA1c均降低（P<0.05和P<0.01），HOMA-β明显升高（P<0.01）。治疗后观察组睾酮水平明显高于治疗前（P<0.01），而对照组治疗前后睾酮水平差异无统计学意义（P>0.05）；治疗前后，2组睾丸酮水平间差异均无统计学意义（P>0.05）。结论：利拉鲁肽能有效降低新诊断T2DM合并肥胖/超重病人血糖，改善胰岛β细胞功能，可提高血浆睾酮水平。

English Abstract

Effect of liraglutide on the plasma testosterone level in T2DM male patiens complicated with obesity/overweight

Corresponding author: SHEN Jing, 副主任医师.shenjingshenhua@126.com

Department of Endocrinololy, The 309 th PLA Hospital, Beijing 100091, China

Received Date: 2017-06-30
Accepted Date: 2018-01-13

Abstract: Objective:To investigate the effects of liraglutide on the plasma testosterone level in type 2 diabetes mellitus(T2DM) male patients complicated with obesity/overweight.Methods:A total of 40 obese or overweight T2DM patients were randomly divided into the control group and observation group(20 cases each group).The control group and observation group were treated with routine method and liraglutide combined with routine method,respectively.After 6 months of treatment,the clinical effiency of liraglutide,and effect of liraglutide on the plasma testosterone level were observed.Results:Before treatment,the differences of the levels of FPG,HbA1c,HOMA-IR and HOMA-β between two groups were not statistically significant(P>0.05).After treatment,the levels of FPG and HbA1c in control group,and all indexes in observation group were significantly improved compared with before treatment(P<0.01).Compared with the control group,the levels of FPG and HbA1c,and level of HOMA-β in observation group significantly decreased and increased after treatment,respectively(P<0.05 to P<0.01).The plasma level of testosterone in observation group after treatment was significantly higher than that before treatment(P<0.01),and the difference of which in control group between before and after treatment was not statistically significant(P>0.05).The differences of the plasma levels of testosterone between two groups were not statistically significant before and after treatment(P>0.05).Conclusions:Liraglutide can effectively reduce the blood glucose,improve the function of pancreas islet β-cells,and enhance the plasma level of testosterone in T2DM patients complicated with obesity or overweight.